Economic Assessment of Direct Cost of Illness of Diabetes Mellitus at Dessie Referral Hospital, North East Ethiopia
Zinash Alemu, Birhanu Demeke Workneh, Solomon Ahmed Mohammed and Moges Workneh Ayele
Article Type: Research Article | First Published: May 06, 2020
Cross-sectional study was conducted on 217 participants from November 30, 2016 to December 31, 2017, and data were extracted from patients registries and analyzed using SPSS version 20. Linear regression was used to assess the statistically significant difference in the cost of treatment of diabetes. The study calculated direct medical and non- medical costs by multiplying the quantity of each service by their respective unit costs. The total direct medical and non-medical costs per year were 12...
Renoprotective Effect of Co-Enzyme Q10 and N-Acetylcysteine on Streptozotocin-Induced Diabetic Nephropathy in Rats
Manojkumar S Mahajan, Chandrashekhar D Upasani, Aman B Upaganlawar and Vishal S Gulecha
Article Type: Original Article | First Published: May 21, 2020
Persistent chronic hyperglycemia is an important player in the development and progression of diabetic nephropathy (DN) due to generation of oxidative stress (OS) which is at the center in the pathophysiology of DN and underlying kidney damage. The present study was aimed to evaluate the effect of antioxidants like Co-enzyme Q10 (CoQ10) and N-acetylcysteine (NAC) either alone or in combination in streptozotocin (STZ) induced diabetic nephropathy (DN) in rats....
The Use of Artifical Intelligence in Assessing Glucose Variability in Individuals with Diabetes Type 2 from Routine Primary Care Data
Ljiljana Trtica Majnarić, MD, PhD, František Babič, MSc, PhD, Zvonimir Bosnić, Marijana Zekić- Sušac, PhD and Thomas Wittlinger, MD, PhD
Article Type: Original Article | First Published: May 06, 2020
A-proof-of-concept study, conducted in primary care. A total of 63 variables were used from electronic health records to describe clinical characteristics of 110 individuals with diabetes type 2 of both gender, 40-86 years old (average 62.69), and on treatment with oral hypoglycaemic drugs. The artificial neural networks (ANN) of machine learning techniques was used to model inter-day glucose variability based on the estimation of variances (the square of the standard deviation) of sporadically ...
Evaluation of Corneal Transparency in Diabetic Patients Aged 60 Years and Over
Luling Yang and Xuemin Li
Article Type: Original Article | First Published: April 16, 2020
The corneal densitometry analysis results varied between different age groups. In the 60 to 69 age group, the anterior layer at zone 0 to 2 mm had better corneal clarity in controls than in DM patients. Corneal densitometry values were markedly higher in diabetic eyes compared with control eyes in 70 to 79 age group when considered by central zones of total cornea at the 2 to 6 mm. The corneal transparency increased in 80 to 89 years DM patients in the majority of corneal zones. Besides, a weak ...
Eliminating the Health Disparity of the Diabetic Foot: A Continuing Public Health Crisis for African Americans and Latinos
Jacqueline E Sharpe, PhD, RN, CHES
Article Type: Review article | First Published: April 30, 2020
The aim of this paper is to maintain attention to the plight of prevention of the diabetic foot ulcer, particularly for those racial/ ethnic minority persons who must not be overlooked for healthcare measures that can save their lives, and for healthcare providers to not allow ones inability to pay be a rejection for not preserving that life and quality of life. The release of the 2020 National Diabetes Statistics Report for the United States continues to show that the ethnic minority groups, ag...